Filing Details

Accession Number:
0001179110-16-019715
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-02-22 12:41:00
Reporting Period:
2016-02-19
Filing Date:
2016-02-22
Accepted Time:
2016-02-22 12:41:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1235010 Momenta Pharmaceuticals Inc MNTA Biological Products, (No Disgnostic Substances) (2836) 043561634
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1308911 E John Bishop C/O Momenta Pharmaceuticals, Inc.
675 West Kendall Street
Cambridge MA 02142
Senior Vp, Pharmaceutical Scie No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-02-19 404 $9.65 109,859 No 4 S Direct
Common Stock Disposition 2016-02-19 1,576 $9.64 108,283 No 4 S Direct
Common Stock Disposition 2016-02-22 868 $9.71 107,415 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2009.
  2. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2015.
  3. This transaction was executed in multiple trades at prices ranging from $9.62 to $9.83. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.